Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2014 1
2015 2
2016 3
2017 3
2018 5
2019 5
2020 6
2021 8
2022 5
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Recent Progress in Lyme Disease and Remaining Challenges.
Bobe JR, Jutras BL, Horn EJ, Embers ME, Bailey A, Moritz RL, Zhang Y, Soloski MJ, Ostfeld RS, Marconi RT, Aucott J, Ma'ayan A, Keesing F, Lewis K, Ben Mamoun C, Rebman AW, McClune ME, Breitschwerdt EB, Reddy PJ, Maggi R, Yang F, Nemser B, Ozcan A, Garner O, Di Carlo D, Ballard Z, Joung HA, Garcia-Romeu A, Griffiths RR, Baumgarth N, Fallon BA. Bobe JR, et al. Among authors: rebman aw. Front Med (Lausanne). 2021 Aug 18;8:666554. doi: 10.3389/fmed.2021.666554. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34485323 Free PMC article. Review.
Disseminated Lyme disease and dilated cardiomyopathy: A systematic review.
Motamed M, Liblik K, Miranda-Arboleda AF, Wamboldt R, Wang CN, Cingolani O, Rebman AW, Novak CB, Aucott JN, Farina JM, Baranchuk A. Motamed M, et al. Among authors: rebman aw. Trends Cardiovasc Med. 2023 Nov;33(8):531-536. doi: 10.1016/j.tcm.2022.05.010. Epub 2022 Jun 3. Trends Cardiovasc Med. 2023. PMID: 35667636 Review.
Gene set predictor for post-treatment Lyme disease.
Clarke DJB, Rebman AW, Fan J, Soloski MJ, Aucott JN, Ma'ayan A. Clarke DJB, et al. Among authors: rebman aw. Cell Rep Med. 2022 Nov 15;3(11):100816. doi: 10.1016/j.xcrm.2022.100816. Cell Rep Med. 2022. PMID: 36384094 Free PMC article.
Cognitive Decline in Post-treatment Lyme Disease Syndrome.
Touradji P, Aucott JN, Yang T, Rebman AW, Bechtold KT. Touradji P, et al. Among authors: rebman aw. Arch Clin Neuropsychol. 2019 Jun 1;34(4):455-465. doi: 10.1093/arclin/acy051. Arch Clin Neuropsychol. 2019. PMID: 29945190
Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.
Fitzgerald BL, Graham B, Delorey MJ, Pegalajar-Jurado A, Islam MN, Wormser GP, Aucott JN, Rebman AW, Soloski MJ, Belisle JT, Molins CR. Fitzgerald BL, et al. Among authors: rebman aw. Clin Infect Dis. 2021 Oct 5;73(7):e2342-e2349. doi: 10.1093/cid/ciaa1455. Clin Infect Dis. 2021. PMID: 32975577 Free PMC article.
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
Morrissette M, Pitt N, González A, Strandwitz P, Caboni M, Rebman AW, Knight R, D'Onofrio A, Aucott JN, Soloski MJ, Lewis K. Morrissette M, et al. Among authors: rebman aw. mBio. 2020 Sep 29;11(5):e02310-20. doi: 10.1128/mBio.02310-20. mBio. 2020. PMID: 32994327 Free PMC article.
39 results